Statistics
Publications
26
Citations
2.1K
H-Index
18
Active since
2000
Lynne Poole is an author at AstraZeneca (United Kingdom) specializing in medicine, pharmacology, and oncology.
Publications per year
2000–2025
26
26
Overall Survival with Osimertinib in Resected <i>EGFR</i> -Mutated NSCLC
Masahiro Tsuboi, Roy S. Herbst, Thomas John et al. · New England Journal of Medicine · 2023 · 612 citations
Medicine, Oncology, Pharmacology +17
Melissa L. Johnson, Byoung Chul Cho, Alexander Luft et al. · Journal of Clinical Oncology · 2022 · 434 citations · Full text
Medicine, Oncology, Pharmacology +17
Rina Hui, Mustafa Özgüroğlu, Augusto Villegas et al. · The Lancet Oncology · 2019 · 192 citations · Full text
Suyash Prasad, Valerie Harpin, Lynne Poole et al. · Current Medical Research and Opinion · 2007 · 97 citations
1–5 of 26